Neal Richardson's departure from SLDC comes with a substantial payout, but the terms of the deal go beyond just money.

Kevin Tang's Concentra Biosciences lines up deal for flailing cancer cell therapy company Cargo Therapeutics — potentially its fourth buyout of a Bay Area biotech this year ...